Spot Commercials Sample Clauses

Spot Commercials. For the making of spot commercials, the Theatre shall give the Actors no less than 48 hours’ notice. All spot commercials shall be made in accordance with the applicable prevailing SAG-AFTRA rules for each performer involved.
Sample 1
AutoNDA by SimpleDocs
Spot Commercials. The Broker will provide, for attachment to the Stations logs, a list of all commercial announcements carried during its Programming. Licensee may waive any of the foregoing regulations in specific instances if, in its reasonable opinion, good broadcasting in the public interest will be served thereby. In any case where questions of policy or interpretation arise, the Broker shall notify Licensee before making any commitments to broadcast any programming affected by such issues.
Sample 1
Spot Commercials. The Programmer will provide, for attachment to the ---------------- Station logs, a list of all commercial announcements carried during its programming. Licensee may waive any of the foregoing regulations in specific instances if, in its reasonable opinion, good broadcasting in the public interest will be served thereby. In any case where questions of policy or interpretation arise, the Programmer shall notify Licensee before making any commitments to broadcast any programming affected by such issues. EXHIBIT "A" TO THE LOCAL PROGRAMMING AND MARKETING AGREEMENT AND PUT/CALL AGREEMENT ASSET PURCHASE AGREEMENT ------------------------ (WGST-FM, Canton, Georgia) This AGREEMENT (the "Agreement") is dated as of _______________, by and between CHEROKEE BROADCASTING CO., INC. ("Seller") and SALEM MEDIA OF GEORGIA, INC. ("Buyer").
Sample 1
Spot Commercials. The Programmer will provide, for attachment to the Station logs, a list of all commercial announcements carried during its Programming. Owner may waive any of the foregoing regulations in specific instances if, in its reasonable opinion, good broadcasting in the public interest will be served thereby. In any case where questions of policy or interpretation arise, the Programmer shall notify Owner before making any commitments to broadcast any programming affected by such issues.
Sample 1
Spot Commercials. The Programmer will provide, for attachment to the Station logs, a list of all commercial announcements carried during its Programming. Owner may waive any of the foregoing regulations in specific instances if, in its reasonable opinion, good broadcasting in the public interest will be served thereby. In any case where questions of policy or interpretation arise, the Programmer shall notify Owner before making any commitments to broadcast any programming affected by such issues. REAL ESTATE PURCHASE AGREEMENT by and among UNIVISION RADIO BROADCASTING TEXAS, L.P. and SALEM RADIO PROPERTIES, INC. Dated as of September 29, 2004 TABLE OF CONTENTS RECITALS 1 ARTICLE I - Terminology 1 ARTICLE II - Purchase and Sale 3 2.1 Real Property 3 2.2 Purchase Price and Method of Payment 4 2.3. Tax Deferred Exchange 4 ARTICLE III - Representations and Warranties of Seller 4 3.1 Organization and Good Standing 4 3.2 Authorization and Binding Effect of Documents 4 3.3 Permitted Use 4 3.4 Stand-Alone Parcel 5 3.5 Compliance with Laws 5 3.6 Certificates of Occupancy, Consents and Approvals 5 3.7 No Condemnation 5 3.8 No Bankruptcy Proceedings 5 3.9 Litigation 5 3.10 Access 5 3.11 Easements 5 3.12 Utilities 6 3.13 Title 6 3.14 Encroachments 6 3.15 Defects 6 3.16 Environmental and other Regulatory Matters 6 3.17 Tower Coordinates 7 3.18 Brokers 8 3.19 Contracts 8 3.20 Representations Complete 8 3.21 Foreign Person 8 ARTICLE V - Transactions Prior to the Closing Date 8 5.1 Conduct of the Real Property Prior to the Closing Date 8 5.2 Access Prior to the Closing Date 9 5.3 Conveyance Free and Clear of Liens 9 5.4 Environmental Assessment 9 5.5 Title and Survey 10 5.6 Confidentiality; Press Release 11 5.7 Press Release 11 ARTICLE VI - Conditions Precedent to the Obligations of Buyer to Close 12 6.1 Accuracy of Representations and Warranties; Closing Certificate 12 6.2 Performance of Agreements 12 6.3 Adverse Proceedings 12 6.4 Delivery of Closing Documents 12 6.5 Environmental Conditions 13 6.6 FCC Consent and Consummation of APA 13 ARTICLE VII - Conditions Precedent of the Obligations of Seller to Close 13 7.1 Accuracy of Representations and Warranties 13 7.2 Performance of Agreements 13 7.3 Adverse Proceedings 13 7.4 Delivery of Closing Documents and Purchase Price 14 7.5 FCC Consent and Consummation of Exchange Agreement 14 ARTICLE VIII - Closing 14 8.1 Time and Place 14 8.2 Deliveries to Buyer by Seller 14 8.3 Deliveries to Seller by Buyer 15 8.4 Prorations and Closing Costs 15 8...
Sample 1
Spot Commercials. If the Ballet wishes to use an existing promotional recording, archival recording or current affairs clip to make a television spot commercial of not more than two (2) minutes duration, the Ballet shall pay each Artist appearing in the final commercial not less than one-sixth (1/6) of their weekly fee for each thirteen week period during which the commercial is aired, except in the case of Clause 24:05.
Sample 1
Spot Commercials. If the Engager wishes to use an existing promotional recording, archival recording or current affairs clip to make a television spot commercial of no more than two (2) minutes duration, the Engager shall pay each Artist appearing in the final commercial not less than one eighth (1/8) of the Artist’s contractual in-town salary for each thirteen week period during which the commercial is aired. Except in the case of Article 24.05 below.
Sample 1
AutoNDA by SimpleDocs

Related to Spot Commercials

  • Marketing Plans Contractor and the Exchange recognize that Enrollees and other health care consumers benefit from efforts relating to outreach activities designed to increase heath awareness and encourage enrollment. The parties shall share marketing plans on an annual basis and with respect to periodic updates of material changes. The marketing plans of the Exchange and Contractor shall include proposed and actual marketing approaches, messaging and channels and provide samples of any planned marketing materials and related collateral as well as planned, and when completed, expenses for the marketing budget. The Contractor shall include this information for both the Exchange and the outside individual market. The Exchange shall treat all marketing information provided under this Section as confidential information consistent with Section 1.4.1. The obligation of the Exchange to maintain confidentiality of this information shall survive termination or expiration of this Agreement.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Commercialization Plans As soon as practicable after formation of the JCC (following Acucela’s exercise of an Opt-In Right under Section 3.1), the JCC shall prepare and approve the initial Commercialization Plan for Commercialization of the Licensed Product for the Initial Indication in the Initial Formulation (and, if applicable, any New Formulation or Other Indication Product) in the Territory. The Parties shall use Commercially Reasonable Efforts to ensure that such initial Commercialization Plan for Commercialization of the Licensed Product for the Initial Indication in the Initial Formulation is consistent with the general Commercialization Plan outline set forth in Exhibit C attached hereto and incorporated herein (the “General Commercialization Plan Outline”). The JCC shall prepare and approve a separate Commercialization Plan for Commercialization of Licensed Product for the Initial Indication in the Initial Formulation in the Territory and for Commercialization of each Other Indication Product and New Formulation (if any) in the Territory, and shall update and amend each Commercialization Plan not less than annually or more frequently as needed to take into account changed circumstances or completion, commencement or cessation of Commercialization activities not contemplated by the then-current Commercialization Plan. Amendments and revisions to the Commercialization Plan shall be reviewed and discussed, in advance, by the JCC, and Otsuka agrees to consider proposals and suggestions made by Acucela regarding amendments and revisions to the Commercialization Plan. Any amendment or revision to the Commercialization Plan that provides for an increase or decrease in the number of FTEs for any Phase 3b Clinical Trials or Post-Approval Studies as compared to the previous version of the Commercialization Plan, or that provides for addition or discontinuation of tasks or activities as compared to the previous version of the Commercialization Plan, or that moves forward the timetable for activities reflected in the Commercialization Plan, shall provide for a reasonable ramp-up or wind-down period, as applicable, to accommodate a smooth and orderly transition of Commercialization activities to the amended or revised Commercialization Plan. Each Commercialization Plan shall identify the goals of Commercialization contemplated thereunder and shall address Commercialization (including Co-Promotion) activities related to the Licensed Product (including, if applicable, any Other Indication Product), including:

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Marketing of Production Except for contracts listed and in effect on the date hereof on Schedule 7.19, and thereafter either disclosed in writing to the Administrative Agent or included in the most recently delivered Reserve Report (with respect to all of which contracts the Borrower represents that it or its Subsidiaries are receiving a price for all production sold thereunder which is computed substantially in accordance with the terms of the relevant contract and are not having deliveries curtailed substantially below the subject Property’s delivery capacity), no material agreements exist which are not cancelable on 60 days notice or less without penalty or detriment for the sale of production from the Borrower’s or its Subsidiaries’ Hydrocarbons (including, without limitation, calls on or other rights to purchase, production, whether or not the same are currently being exercised) that (a) pertain to the sale of production at a fixed price and (b) have a maturity or expiry date of longer than six (6) months from the date hereof.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Marketing Vendor agrees to allow TIPS to use their name and logo within the TIPS website, database, marketing materials, and advertisements unless Vendor negotiates this term to include a specific acceptable-use directive. Any use of TIPS’ name and logo or any form of publicity, inclusive of press release, regarding this Agreement by Vendor must have prior approval from TIPS which will not be unreasonably withheld. Request may be made by email to xxxx@xxxx-xxx.xxx. For marketing efforts directed to TIPS Members, Vendor must request and execute a separate Joint Marketing Disclaimer, at xxxxxxxxx@xxxx-xxx.xxx, before TIPS can release contact information for TIPS Member entities for the purpose of marketing your TIPS contract(s). Vendor must adhere to strict Marketing Requirements once a disclaimer is executed. The Joint Marketing Disclaimer is a supplemental agreement specific to joint marketing efforts and has no effect on the terms of the TIPS Vendor Agreement. Vendor agrees that any images, photos, writing, audio, clip art, music, or any other intellectual property (“Property”) or Vendor Data utilized, provided, or approved by Vendor during the course of the joint marketing efforts are either the exclusive property of Vendor, or Vendor has all necessary rights, license, and permissions to utilize said Property in the joint marketing efforts. Vendor agrees that they shall indemnify and hold harmless TIPS and its employees, officers, agents, representatives, contractors, assignees, designees, and TIPS Members from any and all claims, damages, and judgments involving infringement of patent, copyright, trade secrets, trade or services marks, and any other intellectual or intangible property rights and/or claims arising from the Vendor’s (including Vendor’s officers’, employees’, agents’, Authorized Resellers’, subcontractors’, licensees’, or invitees’) unauthorized use or distribution of Vendor Data and Property.

  • Products Products available under this Contract are limited to Software, including Software as a Service, products and related products as specified in Appendix C, Pricing Index. Vendor may incorporate changes to their product offering; however, any changes must be within the scope of products awarded based on the posting described in Section 1.B above. Vendor may not add a manufacturer’s product line which was not included in the Vendor’s response to the solicitation described in Section 1.B above.

Time is Money Join Law Insider Premium to draft better contracts faster.